Century Therapeutics (IPSC) Amortizatization of Intangibles (2024 - 2026)
Century Therapeutics (IPSC) reported Amortizatization of Intangibles of $211000.0 for Q1 2026, down 75.29% year-over-year from $854000.0 in Q1 2025, and down 39.54% quarter-over-quarter from $349000.0 in Q4 2025.
Century Therapeutics (IPSC) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 3 years of Amortizatization of Intangibles data on file, last reported at $211000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $211000.0, down 75.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 62.34% YoY), and the FY2025 annual result was $2.4 million, down 51.02% from the prior year.
- Amortizatization of Intangibles eased to $211000.0 in Q1 2026 per IPSC's latest filing, from $349000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.3 million in Q2 2024 and troughed at $211000.0 in Q1 2026.
- A 3-year average of $820000.0 and a median of $854000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles declined 23.41% in 2025, then sank 75.29% in 2026.
- A 3-year view of Amortizatization of Intangibles shows it stood at $1.0 million in 2024, then plunged by 66.21% to $349000.0 in 2025, then sank by 39.54% to $211000.0 in 2026.
- Business Quant data shows IPSC's Amortizatization of Intangibles at $211000.0 in Q1 2026, $349000.0 in Q4 2025, and $507000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | 211,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211,000.00 |
| Mar 31, 2026 | 211,000.00 |
| Dec 31, 2025 | 349,000.00 |
| Dec 31, 2025 | 349,000.00 |
| Sep 30, 2025 | 507,000.00 |
| Sep 30, 2025 | 507,000.00 |
| Jun 30, 2025 | 647,000.00 |
| Jun 30, 2025 | 647,000.00 |
| Mar 31, 2025 | 854,000.00 |
| Mar 31, 2025 | 854,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |